November 18, 2022
BioFluidix GmbH, a spin-off resulting from the cooperation between Hahn-Schickard and the Department of Microsystems Engineering at the University of Freiburg, is now part of the Swiss Hamilton Bonaduz AG The strategic acquisition joins two complementary companies: Hamilton Bonaduz, a family-owned company with approximately 4,000 employees worldwide, develops and manufactures dispensing systems and laboratory equipment [...]
Illumina Supports Next Generation Scientists at Genspace
November 18, 2022
Access to cutting edge genomics technology is expanding beyond the walls of industry and the conventional classroom. Illumina and The Illumina Corporate Foundation have granted Genspace in-kind product donations and a cash grant totalling over $100,000 to build capacity for authentic genomics research and project-based learning for New York City youth. The award will come [...]
November 18, 2022
On November 15, Shimadzu Corporation used the prerogative from a stock merger to make Nissui Pharmaceutical Co., Ltd. (hereinafter “Nissui Pharmaceutical,” with Head Office at Taito-ku, Tokyo, and President Tokuya Ono) as a wholly-owned subsidiary. In addition, the corresponding trade name changes and Director/Board Member changes were finalized on November 17 at the Nissui Pharmaceutical [...]
November 18, 2022
The perfect energy-efficient addition – a 400 l size joins the ECO product family. BINDER’s ECO range is growing all the time and maintains a focus not just on precision, but also on an eco-friendly ethos and energy efficiency. Our KB ECO and KBF-S ECO product lines are shining examples of just how it does that. With optimized thermoelectric [...]
November 18, 2022
Yesterday, the genetic laboratory Genotek started to work in Yerevan, Armenia. The main goal is to provide the people of the region with affordable and modern medical technologies and to create new varieties of agricultural plants and animals. YEREVAN, Armenia -- The modern laboratory complex, complete with genomic sequencers and microarray analysis platforms from the U.S. company [...]
Asa Ren and G42 Healthcare Team Up to Advance Genomic Sequencing and Bioinformatics in Indonesia
November 17, 2022
JAKARTA, Indonesia -- Asa Ren Pte Ltd ("Asa Ren"), a leading consumer DNA data company based in Indonesia, has announced a strategic partnership with leading UAE-based Artificial Intelligence technology company, G42 Health Care AI Holding RSC LTD ("G42 Healthcare"). This collaboration is intended to develop and enhance the genomic sequencing and bioinformatics capability in Indonesia in preparation for the Biomedical Genome [...]
New CRISPR/Cas9 Agreement for ERS Genomics and ATLATL
November 17, 2022
Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to announce ATLATL Innovation Centre (‘ATLATL’) as its non-exclusive agent for licensing ERS’ intellectual property for commercial and/or research use in China. ATLATL will now provide access to the foundational CRISPR/Cas9 Intellectual Property held by Dr. Emmanuelle Charpentier. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize [...]
Qlucore software used in new project to prevent cardiovascular diseases
November 17, 2022
– Receives SEK 1.5 million to provide patients with better treatment Nasdaq First North-listed Qlucore, a leading provider of visualization-based software for research and companion diagnostics, will play an important role as one of five key partners in the OmegaPerMed project. The project aims to optimize treatment with omega-3 to prevent cardiovascular diseases (CVD). Cardiovascular [...]
Mesa Labs Acquires Belyntic’s Peptide Purification Business
November 17, 2022
Lakewood, Colorado -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, today announced the acquisition of substantially all of the assets (other than current assets) and certain liabilities related to Belyntic GmbH’s (“Belyntic”) [...]
November 17, 2022
Global biologics leader expands its use of Benchling to create a central source of truth across all R&D. SAN FRANCISCO – Benchling, the R&D Cloud powering the biotechnology industry, today announced that Novozymes, the global leader in biological solutions, will expand the use of the Benchling R&D Cloud across its entire R&D organization. After initially rolling out Benchling [...]
